We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+28.42%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$410M
AUM Growth
-$13.6M
(-3.2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-22.4%
Top 10 Holdings %
Top 10 Hldgs %
19.75%
Holding
160
New
36
Increased
28
Reduced
53
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TechnipFMC
FTI
|
+$5.86M |
| 2 |
Credo Technology Group
CRDO
|
+$5.08M |
| 3 |
CYBR
CyberArk
CYBR
|
+$4.68M |
| 4 |
HealthEquity
HQY
|
+$4.5M |
| 5 |
Kinsale Capital Group
KNSL
|
+$4.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$13.1M |
| 2 |
Abercrombie & Fitch
ANF
|
+$7.93M |
| 3 |
Pinnacle Financial Partners Inc
PNFP
|
+$7.78M |
| 4 |
BLD
TopBuild
BLD
|
+$7.68M |
| 5 |
Webster Financial
WBS
|
+$7.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.13% |
| 2 | Industrials | 24.98% |
| 3 | Healthcare | 17.1% |
| 4 | Consumer Discretionary | 13.96% |
| 5 | Consumer Staples | 5.93% |
Similar funds
GF
PIM
EH
TPWA
ECA
DL
STT
VC
Lisanti Capital Growth's Q1 2024 Portfolio in Review
As of Q1 2024, Lisanti Capital Growth held 160 positions worth $410M, down 3.2% from $424M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lisanti Capital Growth withdrew a net $91.9M in Q1 2024, closing 43 positions and reducing 53 holdings. Its most notable exit was Pinnacle Financial Partners Inc, an estimated $7.78M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Lisanti Capital Growth opened a new position in TechnipFMC worth $7M.
- Lisanti Capital Growth's largest Q1 2024 buy was TechnipFMC: 278,625 shares worth $7M.
- Lisanti Capital Growth added most to Credo Technology Group in Q1 2024, an estimated $5.08M increase.
- Lisanti Capital Growth's biggest Q1 2024 reduction was Viking Therapeutics, cutting an estimated $13.1M.
- Lisanti Capital Growth fully exited Pinnacle Financial Partners Inc in Q1 2024, selling an estimated $7.78M.
- Lisanti Capital Growth's ten largest holdings make up 20% of its $410M portfolio in Q1 2024.
- Lisanti Capital Growth opened 36 new positions and closed 43 in Q1 2024.
- Lisanti Capital Growth's portfolio value fell 3.2% quarter-over-quarter to $410M.
Based on Lisanti Capital Growth's 13F filing for Q1 2024, filed 7 May 2024.